Galena Biopharma (GALE) Reports In-Line Q3 Loss of 9c/Share

Galena Biopharma (NASDAQ: GALE) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Freeport Q3 2026 copper output meets targets; gold sales deferred
• Robinhood shares climb on summit momentum and analyst support